Clinical Trial Update: Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE) [Phase 3]

View source ↗

Summary

Phase 3 study of AHB-137 in chronic hepatitis B patients on nucleos(t)ide analogue therapy is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• AHB-137

Snippet

Sponsor: Ausper Biopharma Co., Ltd. | Conditions: Chronic Hepatitis B | Phase 3 | Status: ACTIVE_NOT_RECRUITING